slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 14,101-14,130
Pages 1,437
Rows per page 30
Arc
14,101-14,130 of 43,093
22
Includes footnotes regarding fund inclusion criteria and NM (Not Meaningful) designations for recent funds.Apollo Global Management | Investor Presentation Deck | 29 slides · Apollo Global Management
Pitch deck Investor relations Beat · Financials1 hit
23
Includes detailed footnotes explaining methodology, currency translation, and specific fund exclusions.Apollo Global Management | Investor Presentation Deck | 29 slides · Apollo Global Management
Pitch deck Investor relations Beat · Financials1 hit
04
BioNTech | Results Presentation Deck | 25 slidesBioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Key Takeaways1 hit
06
The slide uses a horizontal timeline with icons and callouts to mark key regulatory and clinical trial milestones.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · ProblemLoop · Why Now1 hit
07
Includes flags of participating countries, trial flow diagram, and demographic breakdown.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
08
The slide uses color-coding to distinguish between regions with ongoing trials (light green) and those with regulatory submissions on a rolling basis (dark green).BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
09
The slide highlights significant supply commitments across multiple regions, with some financial and volume details withheld.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
10
The slide outlines a cold-chain logistics process for a pharmaceutical product.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
11
BioNTech | Results Presentation Deck | 25 slidesBioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
12
The slide uses a Gantt-style visualization for clinical trial phases.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
13
FIH = First in Human; PRT = Protein Replacement Therapy; 3 = We are eligible to receive worldwide licensesBioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
14
The slide illustrates the biological mechanism of a bispecific antibody targeting PD-L1 and 4-1BB.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
15
The slide uses a staircase diagram to represent dose escalation and a list for expansion cohorts.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
16
Data presented in a table format showing age, gender, cancer type, and prior treatment history.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
17
The chart uses a broken axis between 50 and 100.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
18
Data shows fold change from baseline for four different markers, comparing lower vs higher doses with statistical significance (p-values) indicated.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
19
Waterfall plot showing clinical trial efficacy data.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
20
Waterfall plot (A) and Spider plot (B) showing patient response data.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
22
Financial data presented in millions of Euros.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Financials1 hit
23
The slide uses a two-part structure to separate historical balance sheet data from forward-looking guidance.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Financials1 hit
24
BioNTech | Results Presentation Deck | 25 slidesBioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Key TakeawaysLoop · Quick Win Big Bet1 hit
05
Includes logos for both team affiliations and investor base.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · TeamLoop · Golden Circle1 hit
07
The slide highlights technical capabilities and productivity metrics at the bottom.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a biological interaction map to demonstrate the breadth of the company's target library.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide shows a workflow from a 'toolbox of validated leads' to 'high-throughput expression & characterization' and finally to specific multi-specific constructs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a Gantt-style chart to show the progress of four distinct programs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a timeline framework to track progress of four distinct programs (CTX-471 monotherapy, CTX-471 combo, CTX-8371, and NKp30 platform) plus future programs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
The slide includes a Kaplan-Meier plot showing PFS outcomes for different patient cohorts (PD-1 refractory, immune competent).Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
20
Includes a pharmacokinetic simulation graph and a conceptual dose-response curve illustrating that maximal receptor occupancy may not correlate with optimal biological response.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit